cladribine

Italy

Drugs containing this active substance

  • LEUSTATIN

    LEUSTATIN is indicated for the treatment of hairy cell leukemia (HCL) and for B-cell chronic lymphocytic leukemia (CLL) in patients who have not responded to or whose disease has progressed after treatment with at least one standard protocol containing an alkylating agent.

    Form: solution

    Active substance Dosage
    cladribine -

    ATC: L01BB04

    Manufacturer: ATNAHS PHARMA NETHERLANDS BV

  • LITAK

    LITAK is used to treat hairy cell leukemia by acting on the growth of malignant white blood cells.

    Form: solution for injection

    Active substance Dosage
    cladribine -

    ATC: L01BB04

    Manufacturer: LIPOMED GMBH

  • MAVENCLAD

    The drug is used in the treatment of multiple sclerosis (MS) in adults. It works by reducing disease relapses and slowing the progression of disability.

    Form: tablets

    Active substance Dosage
    cladribine -

    ATC: L04AA40

    Manufacturer: MERCK EUROPE B.V.